Dermal oncogenicity studies on two methoxysilane (cas 18165-31-6)s and two ethoxysilane (cas 18165-31-6)s in male C3H mice

Add time:07/25/2019    Source:sciencedirect.com

The dermal oncogenic potential of β-(3,4-epoxycyclohexyl)ethyltrimethoxysilane (EEMS), γ-glycidoxypropyltrimethoxysilane (GPMS), β-(3,4-epoxycyclohexyl)ethyltriethoxysilane (EEES), and γ-glycidoxypropyltriethoxysilane (GPES) was assessed by applying 25-μl aliquots of acetone solutions to the skin of 40 male C3HHeJ mice. The concentrations applied were 100, 25, 10, and 10% by volume for EEMS, GPMS, EEES, and GPES, respectively. Applications were made thrice weekly until the death of the animals. A negative control group received acetone (solvent) only. No treatment-related skin tumors were observed, nor was there evidence of increased incidence of any internal tumor in the groups that received GPMS, EEES, or GPES. In the group treated with EEMS, four mice were observed with squamous cell carcinomas of the treated skin and two mice had subcutaneous sarcomas outside of the treated area. No skin tumors were observed in the group treated with acetone, but two mice had subcutaneous sarcomas outside of the treated area. The mean survival times were 529, 482, 545, 492, and 502 days for the EEMS, GPMS, EEES, GPES, and acetone control groups, respectively. In no case was the mortality rate significantly different from that of the controls. The results indicate that only EEMS was oncogenic under the conditions of these studies.

We also recommend Trading Suppliers and Manufacturers of ethoxysilane (cas 18165-31-6). Pls Click Website Link as below: cas 18165-31-6 suppliers

Prev:The influence of the addition of alkyl-substituted ethoxysilane (cas 18165-31-6) on the hydrolysis—condensation process of TEOS
Next:H-complexes in the “4-n-alkoxybenzoic acid: 4-pyridyl 4′-n-alkoxybenzoate” system. IR spectroscopy and quantum chemical calculations)